A pair of articles from EMPORER-Preserved examines outcomes in HFpEF patients treated with empagliflozin.
<a href="https://journalclub.wustl.edu/2021/08/27/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/">Empagliflozin in Heart Failure with a Preserved Ejection Fraction | Hospital Medicine Virtual Journal Club</a>
<a href="https://journalclub.wustl.edu/2021/08/30/effect-of-empagliflozin-on-worsening-heart-failure-events-in-patients-with-heart-failure-and-a-preserved-ejection-fraction-the-emperor-preserved-trial/">Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial | Hospital Medicine Virtual Journal Club</a>

One article.
One minute.
100% evidence based.
From the Washington University Hospital Medicine Virtual Journal Club
https://journalclub.wustl.edu/